THC: Tenet Healthcare Corporation Stock

by  •  • Comments Off on THC: Tenet Healthcare Corporation Stock

SIC 8062 – General Medical and Surgical Hospitals

Valuation
Market Cap ($M) 15,805.31
Enterprise Value ($M) 30,448.31
Book Value ($M) 8,653.00
Book Value / Share 45.01
Price / Book 1.83
NCAV ($M) -12,671.00
NCAV / Share -136.42
Price / NCAV -1.25

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.19

Liquidity (mrq)
Quick Ratio 1.70
Current Ratio 1.78

Balance Sheet (mrq) ($M)
Current Assets 7,913.00
Assets 29,237.00
Liabilities 20,584.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 20,665.00
Operating Income 2,907.00
Net Income 3,200.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,047.00
Cash from Investing 3,429.00
Cash from Financing -3,685.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-09 13G/A Invesco Ltd. 4.40 -23.05
04-17 13G/A BlackRock, Inc. 8.80 -22.88
11-14 13G/A Price T Rowe Associates Inc /md/ 7.80 4.72
11-14 13G/A Glenview Capital Management, Llc 2.77 -65.66
11-12 13G Fmr Llc 8.04 70.58

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2025 OR ¨ Transition report pursuant to
2025-02-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K ý Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2024 OR ¨ Transition report pursuant to Sect
2024-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2024 OR ¨ Transition report pursuan
2024-07-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q ý Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2024 OR ¨ Transition report pursuant to

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-02 582,235 1,759,434 33.09
2025-05-30 577,498 1,786,690 32.32
2025-05-29 443,237 1,227,574 36.11
2025-05-28 287,406 1,118,965 25.68

(click for more detail)

Similar Companies
HCA – HCA Healthcare, Inc. MD – Pediatrix Medical Group, Inc.
SEM – Select Medical Holdings Corporation


Financial data and stock pages provided by
Fintel.io